| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer | SVP, Acting CFO | SVP, Finance and CAO +2 more
1 company
Mueller Brian serves as an EVP, Chief Financial Officer at BMRN. Across recent SEC filings that breaks down to 0 buys and 25 sells. Those positions are worth an estimated $6.9M at current prices.
Historically, Mueller Brian's trades have earned a middling insider score of 64/100 across 10 rated trades. Over a 12-month horizon, 70.0% of those trades were profitable, with an average 12-month return of +6.5%.
The biggest single holding is BMRN (~$6.9M) as EVP, Chief Financial Officer. The recent filings there lean toward selling, a net 80,927 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2019 | BMRN Biomarin Pharmaceutical Inc | SVP, Corporate Controller | Sell | 2,953 | $94.00 | $277,582.00 | -17.8% | |
| Aug 7, 2018 | BMRN Biomarin Pharmaceutical Inc | SVP, Corporate Controller | Sale+OE | 2,500 | $104.50 | $261,250.00 | -16.8% | |
| Jun 22, 2018 | BMRN Biomarin Pharmaceutical Inc | SVP, Corporate Controller | Sale+OE | 3,145 | $99.50 | $312,927.50 | -20.3% | |
| Jun 15, 2018 | BMRN Biomarin Pharmaceutical Inc | SVP, Corporate Controller | Sell | 2,021 | $94.50 | $190,984.50 | -13.4% | |
| May 10, 2018 | BMRN Biomarin Pharmaceutical Inc | SVP, Corporate Controller | Sell | 2,450 | $89.50 | $219,275.00 | -13.7% | |
| Jun 22, 2017 | BMRN Biomarin Pharmaceutical Inc | SVP, Corporate Controller | Sale+OE | 2,671 | $100.00 | $267,100.00 | -17.2% | |
| May 8, 2017 | BMRN Biomarin Pharmaceutical Inc | SVP, Corporate Controller | Sale+OE | 7,482 | $91.87 | $687,333.94 | -35.7% | |
| Aug 1, 2016 | BMRN Biomarin Pharmaceutical Inc | VP, Corporate Controller | Sell | 287 | $100.00 | $28,700.00 | -2.0% |